30 results on '"Yopp, Adam"'
Search Results
2. Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy
3. Disparities in Guideline-Concordant Treatment and Survival Among Border County Residents With Gastric Cancer
4. Minimally Invasive Versus Open Pancreaticoduodenectomy: A Propensity-matched Study From a National Cohort of Patients
5. Adoption of evidence‐based novel therapies in the treatment of gastric cancer: A national observational study
6. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma
7. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score–Matched Analysis
8. Reply
9. Patient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis
10. Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability
11. Commentary: Liver regeneration after major hepatectomy: Impact of body mass index
12. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma
13. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
14. Treatment of Liver Cancer
15. Liver Cancer
16. Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio as Predictors of Disease Specific Survival After Resection of Adrenocortical Carcinoma
17. Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
18. Practice Patterns and Attitudes of Primary Care Providers and Barriers to Surveillance of Hepatocellular Carcinoma in Patients With Cirrhosis
19. Surveillance for Hepatocellular Carcinoma: How Can We Do Better?
20. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?
21. Quality improvement initiative: enhanced communication of newly identified, suspected GI malignancies with direct critical results messaging to surgical specialist
22. Presentation, Treatment, and Clinical Outcomes of Patients With Hepatocellular Carcinoma, With and Without Human Immunodeficiency Virus Infection
23. Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization
24. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes
25. Cystic duct biliary adenoma
26. Cardiac Valve Papillary Fibroelastoma: Surgical Excision for Revealed or Potential Embolization
27. Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants
28. TGF-β Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 − Precursors
29. CD4+ CD25+ CD62+ T-Regulatory Cell Subset Has Optimal Suppressive and Proliferative Potential
30. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.